The relationship between sulfonamide resistance genes carried on different plasmids was investigated by restriction enzyme analysis and DNA-DNA hybridization. The results showed that sulfonamide resistance mediated by different plasmids is determined by the production of at least two different types of drugresistant dihydropteroate synthase. Plasmids pGS01, pGS02, and R22259, found in bacteria isolated from patients in Swedish hospitals, contained identical sulfonamide resistance genes, which were also identical to those of plasmids Rl, RIOO, R6, and R388. These latter plasmids, which have been well studied in different laboratories, were originally from clinical isolates from different parts of the world. Two other clinically isolated plasmids, pGS04 and pGS05, were shown to contain sulfonamide resistance determinants of a completely different type.Several studies have indicated that plasmidmediated sulfonamide resistance in Escherichia coli is effected by a duplication of the target, i.e., the expression of a plasmid-borne gene for drugresistant dihydropteroate synthase (EC 2.5.1.15) (16,19,22,26). In a previous study of the enzymological mechanism of sulfonamide resistance, it was shown that the extrachromosomal enzyme differed from its chromosomal counterpart in size, heat lability, and drug inhibition properties. The data, especially those regarding enzyme stability, further suggest the occurrence of at least two types of plasmid-mediated enzymes (22).It has also been observed that in E. coli cells carrying the sulfonamide resistance plasmids R388 and R22259, no resistant enzyme activity could be detected. In the work presented here, the resistance genes from these two plasmids were cloned on a small plasmid with a large number of copies. At this large gene dose, drugresistant enzyme was detected. The resistance genes of the original plasmids thus normally seem to be expressed at a very low level.Other studies have shown that the regions containing sulfonamide resistance are homologous in incFII plasmids RI, R100, and R6 (18).To compare the sulfonamide resistance genes from the clinical isolates descnrbed here, we cloned segments from the different plasmids on the small vector plasmid pBR322. These cloned fragments were compared by restriction enzyme analysis and DNA-DNA hybridization. These analyses supported the classification of plasmidspecified enzymes into two different groups.One group, consisting of Ri, R100, R6, pGS01, pGS02, R388, and R22259, shared a HindIII-BamHI region of 1.3 kiobases (kb) containing the sulfonamide resistance determinant. The other identifiable group comprised pGS04 and pGS05. These two plasmids shared a 1-kb EcoRI fragment, which expressed sulfonamide resistance, when cloned in pBR322. Fragment identities were verified by DNA-DNA hybridization experiments.
MATERIAL D METHODS
Plasmids and btral ins. E. coliC600 (24) and C-167ts20 (19) were used. The plasmids used are listed in Table 1. Meda. LB medium (1), Fraser medium (10), and the mineral salts medium M9 (8) supplemented with...